senolytics

Seragon’s SRN-901: Breakthrough Aging Intervention Drug Achieves Dramatic Lifespan Extension in Preclinical Study

In a May 7, 2024 press release, Seragon Biosciences announced that its aging intervention drug candidate, SRN-901, achieved one of the largest extensions of

November 19, 2024

Biotechnology·Health·Science·Technology

An image of a RESTORIN bottle and the box it came in on a counter top.

Seragon Biosciences’ RESTORIN: A Breakthrough in Targeting Multiple Longevity Pathways

RESTORIN activates key longevity pathways like DNA repair, mTOR inhibition, and cognitive support, offering a scientifically-backed approach to extending healthspan.

October 7, 2024

Biotechnology·Health·Products & Supplements·Science

An image of a man projecting his dividend returns. The image is symbolic of the longevity dividends, in while an ounce of prevention is worth a pound of cure.

Longevity Dividend: What You Need to Know

Scientists are unlocking the secrets of aging, aiming to extend healthy human lifespan through groundbreaking research in senolytics, metformin, and gene editing technologies.

September 19, 2024

Biotechnology·Health·Politics·Science